Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan

Heng Zhai,Yinzhang Lv,Yu Xu,Yi Wu,Weiqi Zeng,Tao Wang,Xuebing Cao,Yan Xu
DOI: https://doi.org/10.1007/s00702-020-02283-y
IF: 3.85
2021-01-01
Journal of Neural Transmission
Abstract:Abstract Information about Parkinson’s disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hospital, Wuhan between 28th January and 29th February 2020 were collected and analyzed. 10 patients (1.96%) had a medical history of PD with a mean (SD) age of 72.10 (± 11.46) years. The clinical characteristics and outcomes of severe COVID-19 with and without PD patients were then compared. There was no significant difference in overall mortality between the PD and non-PD patients with severe COVID-19 ( p > 0.05). In PD patients with severe COVID-19, the proportion of patients with critical type, disturbance of consciousness, incidence of complications, white blood cells count and neutrophils counts on admission seem higher in the non-survivors. PD patients with older age, longer PD duration, and late stage PD may be highly susceptible to critical COVID-19 infection and bad outcome. The PD patients with consciousness disorders and complications that progressed rapidly are at increased risk of death.
neurosciences,clinical neurology
What problem does this paper attempt to address?